Strategies for advancing cancer nanomedicine

被引：669
|
作者：
Chauhan, Vikash P. [1 ,2 ,3 ]
Jain, Rakesh K. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
来源：
NATURE MATERIALS | 2013年 / 12卷 / 11期
关键词：
HUMAN TUMOR XENOGRAFT; IN-VIVO; SOLID TUMORS; VASCULAR-PERMEABILITY; BREAST-CANCER; MICROVASCULAR PERMEABILITY; EXTRACELLULAR-MATRIX; LIPID-COMPOSITION; MOLECULAR-SIZE; DRUG-DELIVERY;
D O I：
10.1038/nmat3792
中图分类号：
O64 [物理化学（理论化学）、化学物理学];
学科分类号：
070304 ; 081704 ;
摘要：
Cancer nanomedicines approved so far minimize toxicity, but their efficacy is often limited by physiological barriers posed by the tumour microenvironment. Here, we discuss how these barriers can be overcome through innovative nanomedicine design and through creative manipulation of the tumour microenvironment.
引用
收藏
页码：958 / 962
页数：5
相关论文
共 50 条
  • [21] Aptamer guided nanomedicine strategies in prostate cancer: Targeting and diagnosis
    Shahrukh, Syed
    Jain, Naitik
    Shah, Saurabh
    Famta, Paras
    Srinivasarao, Dadi A.
    Khatri, Dharmendra Kumar
    Asthana, Amit
    Singh, Shashi Bala
    Raghuvanshi, Rajeev Singh
    Srivastava, Saurabh
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 85
  • [22] Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer
    Lu, Tao
    Prakash, Jai
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 6313 - 6328
  • [23] Cancer targeting strategies in nanomedicine: Design and application of chitosan nanoparticles
    Jee, Jun-Pil
    Na, Jin Hee
    Lee, Sangmin
    Kim, Sun Hwa
    Choi, Kuiwon
    Yeo, Yoon
    Kwon, Ick Chan
    CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE, 2012, 16 (06): : 333 - 342
  • [24] Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy
    Gautam, Rupesh K.
    Mittal, Pooja
    Goyal, Rajat
    Dua, Kamal
    Mishra, Dinesh Kumar
    Sharma, Sanjay
    Singla, Rajeev Kumar
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (28) : 4479 - 4494
  • [25] Current Strategies in Breast Cancer Therapy: Role of Epigenetics and Nanomedicine
    Sengupta, Pallav
    Choudhury, Hira
    Dutta, Sulagna
    Jacob, Shery
    Kesharwani, Prashant
    Gorain, Bapi
    PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION, 2022, 39 (07)
  • [26] Nanomedicine as a multimodal therapeutic paradigm against cancer: on the way forward in advancing precision therapy
    Sandbhor, Puja
    Palkar, Pranoti
    Bhat, Sakshi
    John, Geofrey
    Goda, Jayant S.
    NANOSCALE, 2024, 16 (13) : 6330 - 6364
  • [27] Genetic and epigenetic strategies for advancing ovarian cancer immunotherapy
    Cho, Youngwoo
    Milane, Lara
    Amiji, Mansoor M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (06) : 547 - 560
  • [28] Challenges and strategies in anti-cancer nanomedicine development: An industry perspective
    Hare, Jennifer I.
    Lammers, Twan
    Ashford, Marianne B.
    Puri, Sanyogitta
    Storm, Gert
    Barry, Simon T.
    ADVANCED DRUG DELIVERY REVIEWS, 2017, 108 : 25 - 38
  • [29] Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management
    Tagde, Priti
    Najda, Agnieszka
    Nagpal, Kalpana
    Kulkarni, Giriraj T.
    Shah, Muddaser
    Ullah, Obaid
    Balant, Sebastian
    Rahman, Md. Habibur
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [30] Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy
    Yin, Weimin
    Chang, Jiao
    Sun, Jiuyuan
    Zhang, Tingting
    Zhao, Yuge
    Li, Yongyong
    Dong, Haiqing
    JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (06) : 1171 - 1190
12345